Befesa shares climbed 2.3% to trade at €33.20 as investors reacted to a Morgan Stanley note that kept an Overweight rating on the stock and assigned a EUR 37.00 price target. The broker flagged that Befesa’s EV/EBITDA multiple has fallen well below the peer group average while consensus EBITDA expectations remained unchanged, creating what it described as a buying opportunity at current levels.
In its note, Morgan Stanley also emphasized the company’s strong free cash flow profile, estimating a sector-leading free cash flow yield of around 11%, and presenting that metric as a core element of the bullish case.
Market positioning ahead of quarterly results added momentum. Befesa is scheduled to release Q2 2026 earnings on July 29, and market participants appeared to be increasing exposure ahead of the report. The company’s Q1 2026 results provided a constructive starting point: earnings per share of €0.52 exceeded analyst estimates by a wide margin, net income rose 11% year-on-year, and management reiterated full-year adjusted EBITDA guidance of EUR 250–270 million.
The share advance stood out amid a risk-off move in U.S. markets the same day, when the S&P 500 fell 0.8% and the Nasdaq dropped 1.6%. That broader weakness did not prevent Befesa from trading higher, and the stock reached an intraday high of €34.10 during the session.
Technical and market structure factors also helped the rally. Shares remain about 11% below their 52-week high of €37.40, and a marked decline in short interest through June has eased one source of selling pressure, reducing the potential drag from short covering or renewed bearish positioning.
Contextual summary
- Morgan Stanley maintained an Overweight rating and EUR 37.00 price target, citing valuation compression versus peers and an attractive free cash flow yield.
- Investors are positioning ahead of Q2 2026 results due July 29, supported by a beat in Q1 2026 EPS and confirmation of full-year adjusted EBITDA guidance.
- Shares moved higher despite weakness in major U.S. equity indices and benefited from reduced short interest and a technical setup below the 52-week high.
The combination of analyst endorsement, a clean fundamental backdrop into earnings, and lighter short-side pressure supported Befesa’s uptick even as broader equity markets pulled back.